Skip to main content
logo
XORTX Therapeutics Inc. (TSXV:XRTX)
Canada flag Canada · Delayed Price · Currency is CAD
2.800
-0.040 (-1.41%)
At close: Aug 4, 2026

XORTX Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
55661732
Market Cap Growth
-4.15%-8.88%1.60%-65.60%-48.16%-
Enterprise Value
4.524.232.391.242.7813.62
Last Close Price
2.803.858.4514.4950.40112.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.701.871.230.941.771.94
P/TBV Ratio
2.821.921.541.292.191.89

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0000.000
Net Debt / Equity Ratio
-0.18-0.40-0.73-0.74-1.48-1.13
Net Debt / EBITDA Ratio
0.080.260.610.581.015.15
Net Debt / FCF Ratio
0.090.300.660.521.263.11
Quick Ratio
0.180.822.753.166.9626.97
Current Ratio
0.441.092.963.677.2128.78
Return on Equity (ROE)
-164.30%-98.00%-83.06%-37.08%-76.28%-22.20%
Return on Assets (ROA)
-129.14%-96.13%-86.13%-67.77%-69.04%-30.27%
Return on Invested Capital (ROIC)
-216.87%-223.42%-287.26%-800.78%-1363.21%-401.38%
Return on Capital Employed (ROCE)
-316.59%-138.04%-109.12%-79.44%-74.19%-32.58%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-72.86%-64.48%-45.25%-33.91%-35.25%-47.77%
Total Shareholder Return
-72.86%-64.48%-45.25%-33.91%-35.25%-47.77%